Healthcare professionals' outlook on apalutamide for metastatic hormone sensitive prostate cancer within the ADAPT-P study
Catherine Thompson, Alison Tree, Angela Pathmanathan, R. Davda et autres
0 citationsEuropean Urology Open Science
Darren Leaning
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
30Publications signalées
2525Citations signalées
0Affiliations récentes
Domaines associés
COVID-19 Clinical Research StudiesProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsSARS-CoV-2 and COVID-19 ResearchProstate Cancer Diagnosis and Treatment
Publications récentes
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Kaja Abbas et autres
0 citationsThe Lancet Infectious Diseases
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
11 citationsThe Lancet Infectious Diseases
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Gianmarco Leone, Francesco Orlando, Peter Dutey‐Magni, Osvaldas Vainauskas et autres
5 citationsJAMA Oncology
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jaffar Abbas et autres
3 citationsEClinicalMedicine
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Saul N. Faust, Richard Haynes, Christine E. Jones, Natalie Staplin et autres
40 citationsThe Lancet Child & Adolescent Health
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
41 citationsThe Lancet Diabetes & Endocrinology
Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews
Darren Leaning, Gagandeep Kaur, Alicia K. Morgans, Ray Ghouse et autres
21 citationsFrontiers in Oncology
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Gerhardt Attard, Laura Murphy, Noel W. Clarke, Ashwin Sachdeva et autres
114 citationsThe Lancet Oncology
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres
132 citationsThe Lancet
Eligibility for 177 Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68 Ga-PSMA-11 and 99m Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
Gary Cook, Wai‐Lup Wong, Bal Sanghera, Stephen Mangar et autres
21 citationsJournal of Nuclear Medicine
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres
334 citationsThe Lancet
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.